Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Apr 16, 2026
Home BancShares (HOMB) Delivers Stable Q1 2026 Earnings with Impressive ROA

Home BancShares (HOMB) Delivers Stable Q1 2026 Earnings with Impressive ROA

Key Takeaways

  • Home BancShares reported Q1 2026 net income of $118.2 million, unchanged from Q4 2025 and up 2.6% from Q1 2025.
  • Diluted earnings per share (EPS) came in at $0.60, aligning with consensus estimates of around $0.60.
  • Return on average assets (ROA) reached an impressive 2.09%, underscoring top-tier profitability.
  • Total net revenue totaled $266.7 million, up 2.5% year-over-year but missing analyst expectations of approximately $274 million.
  • Net interest margin (NIM) stood at 4.51%, supported by declining deposit costs; efficiency ratio improved to 41.6%.
  • Deposits grew to $17.74 billion, while non-performing assets (NPAs) ratio rose to 0.97% due to one large loan.

Earnings Context and Why It Matters

From what I see, Home BancShares, Inc., the parent of Centennial Bank, continues to stand out as a strong regional player focused on community banking in fast-growing Southern markets. This Q1 2026 report comes at a pivotal time, with interest rates still posing challenges and deposit competition heating up across banking. The recent completion of the Mountain Commerce Bancorp acquisition on April 1, 2026, adds meaningful scale and geographic reach, which I'm watching closely for its impact. Metrics like ROA and NIM are key here—they reveal how well the bank manages profitability and its balance sheet in a shifting rate environment. Solid numbers suggest resilience, but any cracks in asset quality from commercial lending could raise flags. For investors, the ongoing commitment to dividends and buybacks keeps this attractive.

Diving Into the Reported Results

One thing that stands out is HOMB's Q1 2026 net income of $118.2 million, holding steady from Q4 2025 and up from $115.2 million in Q1 2025. Diluted EPS hit $0.60, right on consensus targets, which points to reliable earnings delivery. Total net revenue climbed to $266.7 million, a 2.5% year-over-year gain but short of the $274 million analysts anticipated—largely from normalizing non-interest income.

I also checked this using Tickeron’s AI Screener to gauge how HOMB stacks up against peers on fundamentals. Pre-tax, pre-provision net revenue (PPNR) grew 3.8% to $152.7 million, thanks to rising net interest income and tight expense management. NIM came in at 4.51%, a slight dip from 4.61% last quarter but steady annually, helped by deposit costs dropping to an average rate of 2.35%. Loans held at $15.63 billion with a minor decline, while deposits rose to $17.74 billion. On asset quality, NPAs ticked up to 0.97% from 0.55% prior quarter, tied to one $92.1 million non-accrual loan; the allowance for credit losses stays robust at 1.90% of loans. Efficiency sharpened to 41.6%, a sign of disciplined operations.

Market Reaction and Investor Sentiment

After the April 15 after-hours release, HOMB shares dipped around 2% in early April 16 trading, hovering near $27.05 in a choppy market. The move balances strong points like that standout ROA and steady EPS against the revenue miss and NPA uptick from a single loan. Sentiment feels cautiously positive—investors appreciate the profitability and rock-solid CET1 ratio of 16.7%, though they're keeping an eye on credit trends and the new acquisition's integration. In my view, the bank's high rankings and active buybacks provide a supportive backdrop.

Tickeron’s AI Screener: A Tool I Rely On

In my research, Tickeron’s AI Screener has become essential for sifting through stocks and ETFs with AI-driven filters on technical patterns, fundamentals, trends, volatility, and signals. It lets me scan thousands of names quickly using criteria like industry, market cap, indicators, price patterns, and performance—spotting trade ideas, breakouts, and opportunities far more efficiently than manual methods. I use it regularly to compare banks like HOMB to the sector, and it streamlines my process without the guesswork.

Forward Outlook and Key Factors to Monitor

The Q1 earnings call on April 16, 2026, offers more color on balance sheet trends and strategy, which I'll be tuning into. That Mountain Commerce Bancorp deal should fuel loan and deposit expansion ahead, but smooth integration is crucial to sidestep cost spikes.

Asset quality is on my radar, especially around that $92.1 million non-accrual and any charge-off risks. Net charge-offs stayed low at $1.4 million, with solid allowance coverage, but commercial real estate in regional banks merits caution amid economic changes.

Rate dynamics will shape NIM—falling deposit costs and 7.08% loan yields are encouraging, though loan growth slowed. Share repurchases (0.25% yield this quarter) and the $0.21 dividend highlight smart capital use. Keep tabs on Q2 deposits, efficiency, and PPNR for evidence of ongoing strength versus peers.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: HOMB

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


HOMB's Stochastic Oscillator sits in oversold zone for 3 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HOMB advanced for three days, in of 290 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 246 cases where HOMB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for HOMB moved out of overbought territory on August 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on August 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HOMB as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for HOMB turned negative on August 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HOMB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. HOMB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.315) is normal, around the industry mean (1.352). P/E Ratio (12.355) is within average values for comparable stocks, (24.338). HOMB's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.825). Dividend Yield (0.029) settles around the average of (0.031) among similar stocks. P/S Ratio (5.339) is also within normal values, averaging (3.769).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are PNC Financial Services Group (NYSE:PNC), US Bancorp (NYSE:USB), Itau Unibanco Banco Holding SA (NYSE:ITUB), Deutsche Bank Aktiengesellschaft (NYSE:DB), Huntington Bancshares (NASDAQ:HBAN), Banco Bradesco SA (NYSE:BBD), Regions Financial Corp (NYSE:RF), KeyCorp (NYSE:KEY).

Industry description

Regional banks have a smaller reach than major banks, and cater mostly to one region of a country, such as a state or within a group of states. They offer services often similar – albeit with some limitations/smaller scale – compared to major banks. Taking deposits, making loans, mortgages, leases, credit cards , fund management, insurance and investment banking. SunTrust Banks, State Street Corp., M&T Bank Corp. are some examples of U.S. regional banks.

Market Cap

The average market capitalization across the Regional Banks Industry is 6.37B. The market cap for tickers in the group ranges from 10.73K to 142.82B. CIHHF holds the highest valuation in this group at 142.82B. The lowest valued company is ACBCQ at 10.73K.

High and low price notable news

The average weekly price growth across all stocks in the Regional Banks Industry was 0%. For the same Industry, the average monthly price growth was -0%, and the average quarterly price growth was 14%. SUPV experienced the highest price growth at 14%, while OPHC experienced the biggest fall at -11%.

Volume

The average weekly volume growth across all stocks in the Regional Banks Industry was 12%. For the same stocks of the Industry, the average monthly volume growth was 1% and the average quarterly volume growth was 24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 54
Price Growth Rating: 48
SMR Rating: 52
Profit Risk Rating: 55
Seasonality Score: -28 (-100 ... +100)
View a ticker or compare two or three
HOMB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a regional bank

Industry RegionalBanks

Profile
Details
Industry
Regional Banks
Address
719 Harkrider
Phone
+1 501 339-2929
Employees
2819
Web
https://www.homebancshares.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.